The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

CenExel announces its role in Vertex Pharma’s studies in Journavx and celebrates US FDA approval: Salt Lake City, Utah Saturday, February 8, 2025, 14:00 Hrs [IST] CenExel, a lea ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...